A Randomized Controlled Single-blind Trial of Transcranial Direct Current Stimulation as Early Augmentation in Major Depressive Disorder: Protocol of a Proof-of-Concept Study

Downloads

Published

2023-03-23

DOI:

https://doi.org/10.55229/ijbs.v26i1.05

Keywords:

Efficacy, Safety, Early Augmentation, Neuromodulation, Depression, tDCS

Dimensions Badge

Issue

Vol. 26 No. 01 (2023): Indian Journal of Behavioural Sciences

Section

ORIGINAL RESEARCH ARTICLES

License

Copyright (c) 2023 Babli Kumari, Sujita K Kar, Amit Singh, Adarsh Tripathi, Vivek Agarwal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

You are free to:

  • The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Crossref
Scopus
Google Scholar
Europe PMC

Authors

  • Babli Kumari King George's Medical Univerisity
  • Sujita K Kar Department of psychiatry, King George’s Medical University, Lucknow, Uttar Pradesh, India
  • Amit Singh Department of psychiatry, King George’s Medical University, Lucknow, Uttar Pradesh, India.
  • Adarsh Tripathi Department of Psychiatry, King George’s Medical University, Lucknow, Uttar Pradesh, India
  • Vivek Agarwal Department of Psychiatry, King George’s Medical University, Lucknow, Uttar Pradesh, India

Abstract

Background: Transcranial direct current stimulation (tDCS) used for augmentation improves depressive symptoms in patients who have a partial or poor response to antidepressant medications. However, its role and effectiveness as an early intervention have not been studied much. This study aims to determine the efficacy and safety of add-on tDCS as an early augmentation strategy in drug-naive patients with major depressive disorder.
Methods: A total of 40 patients will be enrolled in the study, randomized into two groups (active and sham), and receive uniform medication Escitalopram 10 mg per day. A total of 10 sessions of tDCS will be given within 2 weeks. Assessments will be done using scales Hamilton Anxiety Rating Scale (HAM-A), Hamilton Depression Rating Scale (HAM-D) and Beck’s Depression Inventory (BDI) at baseline, week 2, and week 4 of the study. After each session of tDCS, a side effects checklist will be applied to monitor side effects. The trial has been registered in the Clinical Trials Registry, India
(CTRI/2022/01/039123).
Result: After data collection, statistical analysis will be done using a computerized statistical program, Statistical Package for Social Sciences. Mean changes in the rating scale scores will be compared after each assessment and between the groups. Conclusion: The findings will help to assess the efficacy of tDCS in the early augmentation of depressive disorder

How to Cite

Kumari, B., Kar, S. K., Singh, A., Tripathi, A., & Agarwal, V. (2023). A Randomized Controlled Single-blind Trial of Transcranial Direct Current Stimulation as Early Augmentation in Major Depressive Disorder: Protocol of a Proof-of-Concept Study. Indian Journal of Behavioural Sciences, 26(01), 25–30. https://doi.org/10.55229/ijbs.v26i1.05

Downloads

Download data is not yet available.

References

WHO. World mental health report: Transforming mental health for all [Internet]. 2022 [cited 2022 Aug 20]. Available from: https://www.who.int/publications-detail-redirect/9789240049338

Sadock BJ. Kaplan & Sadock’s Synopsis of Psychiatry: Behavioral Sciences/clinical Psychiatry. 11, Illustrated. Wolters Kluwer Publition. https://www. amazon. com/Kaplan-Sadocks-Synopsis …; 2015.

Gautham MS, Gururaj G, Varghese M, Benegal V, Rao GN, Kokane A, et al. The National Mental Health Survey of India (2016): Prevalence, socio-demographic correlates and treatment gap of mental morbidity. International Journal of Social Psychiatry. 2020;0020764020907941.

Gururaj G, Varghese M, Benegal V, Rao G, Pathak K, Singh L, et al. National Mental Health Survey of India, 2015-16 Prevalence, Pattern and Outcomes. 2017.

Depression in adults: treatment and management [Internet]. National Institute for Health and Care Excellence. 2022 [cited 2022 Dec 3]. Available from: https://www.nice.org.uk/guidance/ng222

Gautam S, Jain A, Gautam M, Vahia VN, Grover S. Clinical Practice Guidelines for the management of Depression. Indian J Psychiatry. 2017 Jan;59(Suppl 1):S34–50.

Guideline Development Panel for the Treatment of Depressive Disorders. APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts: (505892019-001) [Internet]. American Psychological Association; 2019 [cited 2022 Oct 16]. Available from: http://doi.apa.org/get-pe-doi.cfm?doi=10.1037/e505892019-001

Mendlewicz J. Towards achieving remission in the treatment of depression. Dialogues Clin Neurosci. 2008 Dec;10(4):371–5.

Seemüller F, Obermeier M, Schennach R, Bauer M, Adli M, Brieger P, et al. Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients. BMC Psychiatry. 2016 May 20;16(1):153.

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018 Apr 7;391(10128):1357–66.

López-López JA, Davies SR, Caldwell DM, Churchill R, Peters TJ, Tallon D, et al. The process and delivery of CBT for depression in adults: a systematic review and network meta-analysis. Psychol Med. 2019 Sep;49(12):1937–47.

Mutz J, Vipulananthan V, Carter B, Hurlemann R, Fu CHY, Young AH. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ. 2019 Mar 27;364:l1079.

Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. 2012 May 1;6:369–88.

Postolache TT, Rosenthal RN, Hellerstein DJ, Aromin R, Kelton GM, Muran JC, et al. Early augmentation of sertraline with methylphenidate. J Clin Psychiatry. 1999 Feb;60(2):123–4.

Razza LB, Palumbo P, Moffa AH, Carvalho AF, Solmi M, Loo CK, et al. A systematic review and meta-analysis on the effects of transcranial direct current stimulation in depressive episodes. Depress Anxiety. 2020 Jul;37(7):594–608.

Singh J, Singh A, Kar SK, Pahuja E. Early Augmentation Response with Low-frequency Repetitive Transcranial Magnetic Stimulation in Treatment Resistant Depression. Clin Psychopharmacol Neurosci. 2017 May;15(2):197–8.

Voigt J, Carpenter L, Leuchter A. A systematic literature review of the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in non-treatment resistant patients with major depressive disorder. BMC Psychiatry. 2019 Jan 8;19:13.

Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F, et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry. 2008 Feb 15;63(4):369–76.

Boggio PS, Rigonatti SP, Ribeiro RB, Myczkowski ML, Nitsche MA, Pascual-Leone A, et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol. 2008 Mar;11(2):249–54.

Brunoni AR, Valiengo L, Baccaro A, Zanao TA, de Oliveira JF, Vieira GP, et al. Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial--SELECT TDCS: design, rationale and objectives. Contemp Clin Trials. 2011 Jan;32(1):90–8.

Loo CK, Alonzo A, Martin D, Mitchell PB, Galvez V, Sachdev P. Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry. 2012 Jan;200(1):52–9.

Lefaucheur JP, Antal A, Ayache SS, Benninger DH, Brunelin J, Cogiamanian F, et al. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clinical Neurophysiology. 2017 Jan 1;128(1):56–92.

Brunoni AR, Sampaio-Junior B, Moffa AH, Aparício LV, Gordon P, Klein I, et al. Noninvasive brain stimulation in psychiatric disorders: a primer. Braz J Psychiatry. 2018 Oct 11;41:70–81.

Kar SK, Menon V. Early augmentation by using neuromodulation in psychiatric disorder: a kaleidoscopic view. CNS Spectrums. 2021 Feb 26;1–3.

Haahr M. RANDOM.ORG - True Random Number Service [Internet]. 1998 [cited 2022 Dec 3]. Available from: https://www.random.org/

G*Power Free Download [Internet]. Heinrich-Heine-University; 2020. Available from: https://g-power.apponic.com/download/

Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56–62.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561–71.

Hamilton MAX. The assessment of anxiety states by rating. British journal of medical psychology. 1959;32(1):50–5.

Eryılmaz G, Hizli Sayar G, Ünsalver B, Gül I, Özten E, Sağlam E. Adverse Effects of Transcranial Direct Current Stimulation (TDCS) in a Group of Psychiatric Patients. Scholars Journal of Applied Medical Sciences. 2014 Feb 28;2014:294–7.

Beam W, Borckardt J. BA9 BA8 BA42 Location System [Internet]. 2010. Available from: http://clinicalresearcher.org/F3/calculate.php

Mir-Moghtadaei A, Caballero R, Fried P, Fox MD, Lee K, Giacobbe P, et al. Concordance Between BeamF3 and MRI-neuronavigated Target Sites for Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex. Brain Stimul. 2015;8(5):965–73.

Fregni F, El-Hagrassy MM, Pacheco-Barrios K, Carvalho S, Leite J, Simis M, et al. Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders. Int J Neuropsychopharmacol. 2020 Jul 26;24(4):256–313.

Wang J, Luo H, Schülke R, Geng X, Sahakian BJ, Wang S. Is transcranial direct current stimulation, alone or in combination with antidepressant medications or psychotherapies, effective in treating major depressive disorder? A systematic review and meta-analysis. BMC Medicine. 2021 Dec 17;19(1):319.

Loo CK, Sachdev P, Martin D, Pigot M, Alonzo A, Malhi GS, et al. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol. 2010 Feb;13(1):61–9.

Most read articles by the same author(s)

1 2 > >>